Genzyme Sues TKT Over Biotech Patent In Israeli Court

Law360, New York (January 25, 2005, 12:00 AM EST) -- Barely a year and a half after Genzyme Corp. and Transkaryotic Therapies Inc. settled their patent disputes with a vow to spend less time in court, the two biotech companies are facing off again before an Israeli judge.

On Tuesday, Genzyme Corp. confirmed it had filed a lawsuit in the District Court of Tel Aviv alleging that Transkaryotic Therapies Inc. has infringed an Israeli patent covering cell culture processes involved in the manufacture of glucocerebrosidase.

TKT is conducting a clinical trial in Israel of its investigational...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.